SEC Form 5 · accession 0001652252-16-000073
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman D Schwartz
Officer — Chairman, President, and CEO · Director · 10% Owner
Period of report
Dec 31, 2015
Accepted (ET)
Feb 10, 2016 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad B Common Stock | Dec 8, 2015 | G | 100 | $0.00 | A | 197,963 | D | |
| Bio-Rad B Common StockF1 | Dec 8, 2015 | G | 100 | $0.00 | A | 12,586 | I | By Spouse |
| Bio-Rad B Common Stock | Dec 17, 2015 | G | 200 | $0.00 | D | 197,763 | D | |
| Bio-Rad A Common Stock | holding | — | — | — | 411,252 | D | ||
| Bio-Rad B Common StockF2 | holding | — | — | — | 4,060,054 | I | By Blue Raven Partners, L.P. | |
| Bio-Rad B Common StockF3 | holding | — | — | — | 13,726 | I | By DANSA Partnership |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these shares.
- F2The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F3The shares are held by a limited partnership of which the reporting person is a limited partner.